Concepedia

Elizabeth Alexander

EA

Statistics

Publications

35

Citations

2.1K

H-Index

20

Active since

1995

Affiliations

VIR Biotechnology (United States)(Current)

Doctors Company (United States)

The University of Western Australia

University of Manchester

Cornell University

Elizabeth Alexander is an author at VIR Biotechnology (United States) specializing in life sciences, pharmacotherapy, and infectious diseases.

Publications per year

1995–2024

35

Publications

35

Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

Richard G. Wunderink, Evangelos J. Giamarellos‐Bourboulis, Galia Rahav et al. · Infectious Diseases and Therapy · 2018 · 442 citations · Full text

, , +17

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection

Keith S. Kaye, Tanaya Bhowmick, Symeon Metallidis et al. · JAMA · 2018 · 306 citations · Full text

, , +17

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · JAMA · 2022 · 294 citations · Full text

, , +12

Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia

Elizabeth Alexander, Lisa Goldberg, Anita Das et al. · JAMA · 2019 · 108 citations · Full text

, , +15

Hierarchical expression of genes controlled by the <i>Bacillus subtilis</i> global regulatory protein CodY

Shaun R. Brinsmade, Elizabeth Alexander, Jonathan Livny et al. · Proceedings of the National Academy of Sciences · 2014 · 107 citations · Full text

, , +17

1–5 of 35